Sam Di Giacomo

Mr di Giacomo brings 17 years of experience to APAC. He has been involved in numerous capital raisings at all stages from seed to IPO, and has been involved in a number of technology and distribution licensing deals. He is also a founder of a number of Australian life science companies including pSimedica Ltd, Australian Cancer Technology (now Avantogen Limited), Resonance Health Ltd, and founding director of Advance Healthcare Group Limited.